Navigation Links
HHS Names First Director of the Biomedical Advanced Research Development Authority
Date:4/14/2008

WASHINGTON, April 14 /PRNewswire-USNewswire/ -- The Department of Health and Human Services today announced the selection of Robin Robinson, Ph.D., as the first director of the Biomedical Advanced Research Development Authority (BARDA), which was established in 2007 in the HHS Office of the Assistant Secretary for Preparedness and Response.

"Robin is an excellent choice for BARDA Director," said HHS Assistant Secretary for Preparedness and Response RADM Craig Vanderwagen, M.D., USPHS. "Robin was the strongest candidate to emerge in our nationwide search, and his extensive experience in industry and government concretely demonstrates his ability to succeed."

In his current role as Deputy Director of BARDA's Influenza and Emerging Disease Program, Dr. Robinson led the successful development, procurement and stockpiling of the world's first H5N1 influenza vaccine approved for human use, which was cited by Time Magazine as the number one medical breakthrough in 2007.

"I am delighted that Robin Robinson has been named as the Director of BARDA. Robin brings scientific, public health and industry experience to a position that is critical to our emergency preparedness strategy," said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. "His leadership qualities, keen perspective and broad expertise will contribute greatly to the success of the program."

BARDA was established in the HHS Office of the Assistant Secretary for Preparedness and Response in 2007. BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, nuclear agents, as well as manages the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield.

Note: All HHS press r
'/>"/>

SOURCE U.S. Department of Health and Human Services
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... A cleanroom manufacturing company has ...eanrooms. The feature is a utility panel which ca...nce the cleanroom appearance. , ...Gerbig Engineering, a designer, fabricator and ins...they are now offering a utility panel for integrat...
(Date:7/23/2008)...und,s Commitment to Meet the Financing Needs of Eu...and Institutions--, NEW YORK, July 24 /PRNewswire...n Macleod, Ph.D., has been promoted to Partner. Ba...s responsible for sourcing,evaluating and negotia...rtunities for the Paul Capital Healthcare funds., ...
(Date:7/23/2008)...M, N.C. A study out of Wake Forest University Bap...ctors are correctly identifying patients who are h...aven,t yet confirmed it. , The study used data f...ts with heart attack symptoms who were admitted to...g U.S. centers. , The findings were released to...
(Date:7/23/2008)...d Problem For 10+ Years Even Though Some Kilns Emi...n Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, ...wire-USNewswire/ -- For more than a decade,after C...n from cement,kilns across the nation, the U.S. En...e action. Now, a new study from Earthjustice and t...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
...o run the U.S. Food and Drug Administration, said ...ure while scientific decisions were being made//. ...ffectiveness of medical endeavors, the appropriate...ration. Dr. Andrew Eschenbach, acting administrat...
...uth Wales has conducted a study which revealed tha...the user's physical health// . It is one of the ...Cannabis abuse can lead to cardiovascular, respira.... It can decrease short-term memory and also slow...
... from the University of Michigan and Harvard Unive...o explore how different regions// of the brain are...f brands and products. The study, forthcoming in t...e first to use fMRI to assess consumer perceptions...
...D is important for bone development and may help p... particularly// colorectal cancer.To be effective ... needed and this can be dangerous and toxis. Now, ...di Comprehensive Cancer Center indicates that it m...
Other Medicine News:Health News:FDA Nominee Says That He Is Not Influenced By Politics 2Health News:Anticancer Properties of Vitamin D Revealed 2Health News:Anticancer Properties of Vitamin D Revealed 3
(Date:7/23/2008)..., July 23 /- Sound Pharmaceuticals (S...ion with the FDA for the clinical,testing of a pro... of,chemotherapy induced hearing loss or ototoxici... will be tested in advanced stage lung cancer,and ...ased chemotherapy.,This marks the second developme...
(Date:7/23/2008)..., July 23 /- Dendreon Corpo...pects the Independent Data,Monitoring Committee (I...s,of overall survival relating to the Company,s Ph...inoma Treatment, also known as D9902B) clinical tr... Company,s investigational,active cellular immunot...
(Date:7/22/2008)...awards under Therapeutics Development Initiative b... to 23; next deadline January 20,2009, NEW YORK,... mission to,speed delivery of transformative treat...ael J. Fox Foundation for Parkinson,s Research has...stry research teams. The awards,were granted under...
(Date:7/22/2008)...frey Allan Will Stress the Importance to Patients ...Approval Pathway, RICHMOND, Va., July 22 /PRNewsw...developer of follow-on biologics and biopharmaceut... CEO of Insmed, will present at a,Congressional br...ignificant need for establishing an approval pathw...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4Interferon does not slow or stop hepatitis C from worsening study finds 5962 1Interferon does not slow or stop hepatitis C from worsening study finds 5962 2UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2Pill Poses Little Cervical Cancer Risk 5956 1Pill Poses Little Cervical Cancer Risk 5956 2Pill Poses Little Cervical Cancer Risk 5956 3
Our Tri-Flo® suction catheter design was created to be less traumatic to your patients while still providing high suctioning efficiency. Our infant and pediatric catheters (5/6, 8 or 10 Fr) featu
Tracheal Suction Latex Rubber Catheters - Funnel End
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip.
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning.
Medicine Products: